Community Questions & Discussions

Exploring the Potential of GLPG3667 in Treating Active Lupus: What's Your Take?

I recently came across a study titled 'A Study Evaluating the Effects of GLPG3667 Administered as Oral Treatment in Adult Patients With Active Lupus'. The goal of this trial is to assess the efficacy and safety of this experimental treatment. What are your thoughts on this study? Do you believe that...

  • By Admin

Thoughts on the Voclosporin Clinical Trial for Lupus Nephritis in Teens?

I recently came across the 'Long-Term Voclosporin Treatment in Adolescent Subjects With Lupus Nephritis' study, and I'm curious to hear your thoughts. For those unfamiliar, lupus nephritis is a severe complication of lupus that affects the kidneys. This study explores the use of voclosporin, an immu...

  • By Admin

Thoughts on the 'Characteristics and Disease Progression of Mixed Connective Tissue Disease and Lupus' Study?

I recently came across the 'Characteristics and Disease Progression of Mixed Connective Tissue Disease and Lupus' study, and I'm curious to hear your thoughts on the approach they took to address lupus challenges. The study focused on understanding the progression of these diseases and identifying p...

  • By Admin

Sharing thoughts on the 'A Prospective Observational Registry of Patients Treated With LUPKYNIS® (Voclosporin) in the US' study

Have any of you heard about or participated in the 'A Prospective Observational Registry of Patients Treated With LUPKYNIS® (Voclosporin) in the US' study? I'm curious to know your thoughts on the goals and outcomes of this clinical trial for lupus patients. What impact could this research have on ...

  • By Admin

Discussing the Anifrolumab Study & Its Impact on Lupus Vascular Risk

I recently came across the study titled 'The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Lupus (SLE) - IFN-CVD'. This phase III trial investigates whether anifrolumab, an interferon-alpha receptor antagonist, can improve vascular risk in lupus patients. What are your t...

  • By Admin

Thoughts on the 'Prevalence and Clinical Severity of Cutaneous Lupus Erythematosus' study approach?

I've been reading about the 'Prevalence and Clinical Severity of Cutaneous Lupus Erythematosus' study and was curious to hear your thoughts on the approach they took to address lupus challenges. What are your opinions on the use of clinical trials to study autoimmune diseases like lupus?...

  • By Admin

Thoughts on the 'Intervention to Improve Communication and Medication Adherence in Lupus' study?

I recently came across the 'Intervention to Improve Communication and Medication Adherence in Lupus' study, which aims to address some of the challenges faced by lupus patients. The study focuses on improving communication between healthcare providers and patients, as well as medication adherence. W...

  • By Admin

Shingles Vaccine and Lupus: What Do Clinical Trials Tell Us?

I recently came across a study titled 'Safety of the Herpes Zoster Subunit Vaccine in Lupus' and it got me thinking about the goals and outcomes of clinical trials for lupus and other autoimmune diseases. What are your thoughts on this specific study and how it might impact the lupus community?...

  • By Admin

Thoughts on the 'Tissue Repository Providing Annotated Biospecimens' Study for Lupus Research?

I recently came across the 'Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives' study, which aims to address challenges in lupus research. The approach involves collecting and analyzing biospecimens from lupus patients to better unde...

  • By Admin

Thoughts on the ALXN2050 Study for Lupus Nephritis and IgAN?

I recently came across the 'Study of ALXN2050 in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN)' and I'm curious to hear your thoughts on the approach they're taking. How do you feel about the potential of this study for addressing lupus challenges?...

  • By Admin

Thoughts on the NAD+ Boosting Study for Lupus and Its Potential Impact on Autoimmune Diseases

Have you heard about the recent double-blind placebo-controlled study on NAD+ boosting with Nicotinamide Riboside and its effects on immunometabolism and immunity in lupus? The study's main goal is to evaluate the potential benefits of Nicotinamide Riboside in improving the lives of those with lupus...

  • By Admin

Thoughts on the 'Study of Lupus' Clinical Trial?

I recently came across a clinical trial for lupus called 'Study of Lupus' and I'm curious to hear what others think about it. The study aims to evaluate the safety and efficacy of an investigational medication for lupus patients. With so many people affected by this autoimmune disease, it's great to...

  • By Admin

Thoughts on the Ravulizumab Study for Lupus Nephritis and IgAN?

I recently came across the 'Study of Ravulizumab in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN)' and I'm curious to hear what others think about this approach to addressing lupus challenges? The study uses Ravulizumab, a monoclonal antibody, to target the complement sys...

  • By Admin

Thoughts on the WILLOW LTE Study: A New Approach to Tackling Lupus?

Have any of you heard about or followed the 'The Willow LTE Study With M5049 in Patients With SCLE, DLE and/or SLE (WILLOW LTE)' study? The researchers are investigating the potential benefits of a new drug, M5049, in treating specific types of lupus. I'm curious to hear your thoughts on this approa...

  • By Admin

Thoughts on the Deucravacitinib Clinical Trial for Lupus Patients?

I recently came across the 'A Study to Assess Effectiveness and Safety of Deucravacitinib Compared With Placebo in Patients With Active Lupus (SLE)' study and was wondering how the community feels about this approach to addressing lupus challenges. What are your thoughts?...

  • By Admin

Total Threads: 90 - 182